CNS: Translating Discoveries into Therapeutics Summit 2018

Topics

• State of art CNS models and better understandable mechanism of action
• Novel and emerging CNS targets and biomarkers
• Strategic developments in neuro-pharmaceuticals, devices, and diagnostics
• Recent discoveries in neuro -imaging, -inflammation, -immunology, -degeneration, psychiatry and neurology
• Overcoming challenges to CNS drug delivery associated with blood-brain barrier (BBB)
• Advanced translational CNS strategies
• Bridging science and tech to cover translational gap and to accelerate novel CNS therapeutics Investment perspectives into neuroscience and new neurotech

Who should Attend

Attendees involved or interested in:

• Neurodegenerative diseases
• Central Nervous System
• Translational Neuroscience
• Computational Neuroscience
• Neuroimmunology
• Neuropharmacology
• Neuroengineering
• Neurology
• Stem Cells
• Neuropharmaceuticals
• Brain
• Neurodevices
• Blood Brain Barrier (BBB)
• Spinal Disorders
• Autism
• Arachnoid cysts
• Encephalitis
• Catalepsy
• Meningitis
• Infection
• Alzheimer’s diseases
• Multiple sclerosis
• Sleep disorders
• Parkinson`s diseases
• Neuroimaging / Brain Imaging
• Neuroscience
• Neuroinformatics
• Cognitive Neuroscience
• Neurogenetics
• Neurobiology
• Novel Neurotherapeutics
• Neurotechnology
• Cell & Gene Therapies
• Central Nervous System Regenerative Medicine
• Brain Stem
• Neurodiagnostics
• Addiction
• Biomarkers
• Bipolar disorder
• Attention deficit/hyperactivity disorder (ADHD)
• Epilepsy/Seizures
• Depression
• Migraine
• Locked-in syndrome
• Huntington`s disease
• Myelopathy
• Tourette`s diseases